Advancing Lymphoma Treatment in Singapore: Personalised Cancer Care at CFCH
Lymphoma, or cancer of the lymph glands is one of the most common types of cancers in Singapore. Diffuse large B-cell lymphoma (DLBCL) is a significant form of lymphoma. A diagnosis of lymphoma, especially Diffuse Large B-Cell Lymphoma (DLBCL), can be overwhelming. But for patients with lymphoma in Singapore, hope for a cure is real […]
Treatment Options of Relapsed/Refractory Diffuse Large B cell Lymphoma (DLBCL)
“Relapsed” means the disease comes back after an improvement, while “refractory” means the lymphoma is not responding to treatment or the response is very short-lived. The majority (Up to 50-60%) of patients with Diffuse Large B cell lymphoma (DLBCL) can be potentially cured with standard chemoimmunotherapy, R-CHOP. 1 Even amongst patients who progress during initial […]
Role of Immunotheraphy in Cancer
Media Dr Lim Zi Yi was invited to the Ee Hoe Hian club to give a talk on the role of Immunotherapy in Cancer. At the same time there was a healthy panel discussion on the roles of both ‘Western’ and Chinese medicine in cancer patients. Read From Source Share it : Latest Media Blood […]